These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 28202740)

  • 21. Outcome reporting in randomized trials in gout: A systematic scoping review from the OMERACT gout working group assessing the uptake of the core outcome set.
    Morillon MB; Nørup A; Singh JA; Dalbeth N; Taylor WJ; Kennedy MA; Pedersen BM; Grainger R; Tugwell P; Perez-Ruiz F; Diaz-Torne C; Edwards NL; Shea B; Ellingsen TJ; Christensen R; Stamp LK;
    Semin Arthritis Rheum; 2023 Jun; 60():152191. PubMed ID: 36963128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Achieving Consensus on Total Joint Replacement Trial Outcome Reporting Using the OMERACT Filter: Endorsement of the Final Core Domain Set for Total Hip and Total Knee Replacement Trials for Endstage Arthritis.
    Singh JA; Dowsey MM; Dohm M; Goodman SM; Leong AL; Scholte Voshaar MMJH; Choong PF
    J Rheumatol; 2017 Nov; 44(11):1723-1726. PubMed ID: 28089984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Preliminary Core Domain Set for Clinical Trials of Shoulder Disorders: A Report from the OMERACT 2016 Shoulder Core Outcome Set Special Interest Group.
    Buchbinder R; Page MJ; Huang H; Verhagen AP; Beaton D; Kopkow C; Lenza M; Jain NB; Richards B; Richards P; Voshaar M; van der Windt D; Gagnier JJ;
    J Rheumatol; 2017 Dec; 44(12):1880-1883. PubMed ID: 28089972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Core Domain Set Selection According to OMERACT Filter 2.1: The OMERACT Methodology.
    Maxwell LJ; Beaton DE; Shea BJ; Wells GA; Boers M; Grosskleg S; Bingham CO; Conaghan PG; D'Agostino MA; de Wit M; Gossec L; March L; Simon LS; Singh JA; Strand V; Tugwell P
    J Rheumatol; 2019 Aug; 46(8):1014-1020. PubMed ID: 30770502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Towards development of core domain sets for short term and long term studies of calcium pyrophosphate crystal deposition (CPPD) disease: A framework paper by the OMERACT CPPD working group.
    Cai K; Fuller A; Zhang Y; Hensey O; Grossberg D; Christensen R; Shea B; Singh JA; McCarthy GM; Rosenthal AK; Filippou G; Taylor WJ; Diaz-Torne C; Stamp LK; Edwards NL; Pascart T; Becce F; Nielsen SM; Tugwell P; Beaton D; Abhishek A; Tedeschi SK; Dalbeth N
    Semin Arthritis Rheum; 2021 Aug; 51(4):946-950. PubMed ID: 34140183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current Status, Goals, and Research Agenda for Outcome Measures Development in Behçet Syndrome: Report from OMERACT 2014.
    Hatemi G; Ozguler Y; Direskeneli H; Mahr A; Gul A; Levi V; Aydin SZ; Mumcu G; Sertel-Berk O; Stevens RM; Yazici H; Merkel PA
    J Rheumatol; 2015 Dec; 42(12):2436-41. PubMed ID: 26373563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An OMERACT Initiative Toward Consensus to Identify and Characterize Candidate Contextual Factors: Report from the Contextual Factors Working Group.
    Finger ME; Boonen A; Woodworth TG; Escorpizo R; Christensen R; Nielsen SM; Leong AL; Scholte Voshaar M; Flurey CA; Milman N; Verstappen SM; Alten R; Guillemin F; Kloppenburg M; Beaton DE; Tugwell PS; March LM; Furst DE; Pohl C
    J Rheumatol; 2017 Nov; 44(11):1734-1739. PubMed ID: 28461648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toward a generalized framework of core measurement areas in clinical trials: a position paper for OMERACT 11.
    Boers M; Idzerda L; Kirwan JR; Beaton D; Escorpizo R; Boonen A; Magasi S; Sinha I; Stucki G; Tugwell P
    J Rheumatol; 2014 May; 41(5):978-85. PubMed ID: 24584922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced Patient Involvement and the Need to Revise the Core Set - Report from the Psoriatic Arthritis Working Group at OMERACT 2014.
    Tillett W; Eder L; Goel N; De Wit M; Gladman DD; FitzGerald O; Campbell W; Helliwell PS; Gossec L; Orbai AM; Ogdie A; Strand V; McHugh NJ; Mease PJ
    J Rheumatol; 2015 Nov; 42(11):2198-203. PubMed ID: 25934828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0.
    Boers M; Kirwan JR; Wells G; Beaton D; Gossec L; d'Agostino MA; Conaghan PG; Bingham CO; Brooks P; Landewé R; March L; Simon LS; Singh JA; Strand V; Tugwell P
    J Clin Epidemiol; 2014 Jul; 67(7):745-53. PubMed ID: 24582946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Core outcome measurement instrument selection for physical function in hand osteoarthritis using the OMERACT Filter 2.1 process.
    Kroon FPB; van der Heijde D; Maxwell LJ; Beaton DE; Abishek A; Berenbaum F; Blanco FJ; Conaghan PG; Dziedzic K; Hill CL; Haugen IK; Ishimori M; Ritschl V; Stamm TA; Wittoek R; Kloppenburg M
    Semin Arthritis Rheum; 2021 Dec; 51(6):1311-1319. PubMed ID: 34538514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Worker productivity outcome measures: OMERACT filter evidence and agenda for future research.
    Tang K; Boonen A; Verstappen SM; Escorpizo R; Luime JJ; Lacaille D; Fautrel B; Bosworth A; Cifaldi M; Gignac MA; Hofstetter C; Leong A; Montie P; Petersson IF; Purcaru O; Bombardier C; Tugwell PS; Beaton DE
    J Rheumatol; 2014 Jan; 41(1):165-76. PubMed ID: 24128774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility and Domain Validation of Rheumatoid Arthritis (RA) Flare Core Domain Set: Report of the OMERACT 2014 RA Flare Group Plenary.
    Bartlett SJ; Bykerk VP; Cooksey R; Choy EH; Alten R; Christensen R; Furst DE; Guillemin F; Halls S; Hewlett S; Leong AL; Lyddiatt A; March L; Montie P; Orbai AM; Pohl C; Voshaar MS; Woodworth TG; Bingham CO
    J Rheumatol; 2015 Nov; 42(11):2185-9. PubMed ID: 25684764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation studies of rheumatoid arthritis patient-reported outcome measures in populations at risk for inequity: A systematic review and analysis using the OMERACT summary of measurement properties equity table.
    Barnabe C; Wattiaux A; Petkovic J; Beaton D; Shea B; Greer-Smith R; Humphreys J; Bartels C; Tugwell P; Umaefulam V
    Semin Arthritis Rheum; 2022 Aug; 55():152029. PubMed ID: 35640489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishing an Updated Core Domain Set for Studies in Juvenile Idiopathic Arthritis: A Report from the OMERACT 2018 JIA Workshop.
    Morgan EM; Munro JE; Horonjeff J; Horgan B; Shea B; Feldman BM; Clairman H; Bingham CO; Thornhill S; Strand V; Alongi A; Magni-Manzoni S; van Rossum MAJ; Vesely R; Vojinovic J; Brunner HI; Harris JG; Horton DB; Lovell DJ; Mannion M; Rahimi H; Ravelli A; Ringold S; Ruperto N; Schrandt MS; Shenoi S; Shiff NJ; Toupin-April K; Tzaribachev N; Weiss P; Consolaro A
    J Rheumatol; 2019 Aug; 46(8):1006-1013. PubMed ID: 30770499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient Endorsement of the Outcome Measures in Rheumatology (OMERACT) Total Joint Replacement (TJR) clinical trial draft core domain set.
    Singh JA; Dowsey M; Choong PF
    BMC Musculoskelet Disord; 2017 Mar; 18(1):111. PubMed ID: 28298194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do outcomes reported in randomised controlled trials of joint replacement surgery fulfil the OMERACT 2.0 Filter? A review of the 2008 and 2013 literature.
    Wall PDH; Richards BL; Sprowson A; Buchbinder R; Singh JA
    Syst Rev; 2017 May; 6(1):106. PubMed ID: 28558822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The evolution of instrument selection for inclusion in core outcome sets at OMERACT: Filter 2.2.
    Maxwell LJ; Beaton DE; Boers M; D'Agostino MA; Conaghan PG; Grosskleg S; Shea BJ; Bingham Iii CO; Boonen A; Christensen R; Choy E; Doria AS; Hill CL; Hofstetter C; Kroon FP; Leung YY; Mackie S; Meara A; Touma Z; Tugwell P; Wells GA
    Semin Arthritis Rheum; 2021 Dec; 51(6):1320-1330. PubMed ID: 34544617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Engaging Stakeholders and Promoting Uptake of OMERACT Core Outcome Instrument Sets.
    Tunis SR; Maxwell LJ; Graham ID; Shea BJ; Beaton DE; Bingham CO; Brooks P; Conaghan PG; D'Agostino MA; de Wit MP; Gossec L; March LM; Simon LS; Singh JA; Strand V; Wells GA; Tugwell P
    J Rheumatol; 2017 Oct; 44(10):1551-1559. PubMed ID: 28765256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety Working Group.
    Berthelsen DB; Simon LS; Ioannidis JPA; Voshaar M; Richards P; Goel N; Strand V; Nielsen SM; Shea BJ; Tugwell P; Bartlett SJ; Hazlewood GS; March L; Singh JA; Suarez-Almazor ME; Boers M; Stevens RM; Furst DE; Woodworth T; Leong A; Brooks PM; Flurey C; Christensen R;
    Semin Arthritis Rheum; 2023 Dec; 63():152288. PubMed ID: 37918049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.